|
Originally published In Press as doi:10.1074/jbc.M606192200 on September 14, 2006
J. Biol. Chem., Vol. 281, Issue 44, 33182-33191, November 3, 2006
Heat Shock Proteins 70 and 90 Inhibit Early Stages of Amyloid -(142) Aggregation in Vitro*
Christopher G. Evans,
Susanne Wisén, and
Jason E. Gestwicki1
From the
Department of Pathology and the Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109
Alzheimer disease is a neurological disorder that is characterized by the presence of fibrils and oligomers composed of the amyloid (A ) peptide. In models of Alzheimer disease, overexpression of molecular chaperones, specifically heat shock protein 70 (Hsp70), suppresses phenotypes related to A aggregation. These observations led to the hypothesis that chaperones might interact with A and block self-association. However, although biochemical evidence to support this model has been collected in other neurodegenerative systems, the interaction between chaperones and A has not been similarly explored. Here, we examine the effects of Hsp70/40 and Hsp90 on A aggregation in vitro. We found that recombinant Hsp70/40 and Hsp90 block A self-assembly and that these chaperones are effective at substoichiometric concentrations ( 1:50). The anti-aggregation activity of Hsp70 can be inhibited by a nonhydrolyzable nucleotide analog and encouraged by pharmacological stimulation of its ATPase activity. Finally, we were interested in discerning what type of amyloid structures can be acted upon by these chaperones. To address this question, we added Hsp70/40 and Hsp90 to pre-formed oligomers and fibrils. Based on thioflavin T reactivity, the combination of Hsp70/40 and Hsp90 caused structural changes in oligomers but had little effect on fibrils. These results suggest that if these chaperones are present in the same cellular compartment in which A is produced, Hsp70/40 and Hsp90 may suppress the early stages of self-assembly. Thus, these results are consistent with a model in which pharmacological activation of chaperones might have a favorable therapeutic effect on Alzheimer disease.
Received for publication, June 28, 2006
, and in revised form, August 15, 2006.
* This work was supported by the University of Michigan Alzheimer Disease Research Center Grant P50 AG08671. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed. Tel.: 734-615-9537; Fax: 734-764-1075; E-mail: gestwick{at}umich.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Morishima, A. M. Wang, Z. Yu, W. B. Pratt, Y. Osawa, and A. P. Lieberman
CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins
Hum. Mol. Genet.,
December 15, 2008;
17(24):
3942 - 3952.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Tetzlaff, P. Putcha, T. F. Outeiro, A. Ivanov, O. Berezovska, B. T. Hyman, and P. J. McLean
CHIP Targets Toxic {alpha}-Synuclein Oligomers for Degradation
J. Biol. Chem.,
June 27, 2008;
283(26):
17962 - 17968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zhao, Y. Kakihara, A. Gribun, J. Huen, G. Yang, M. Khanna, M. Costanzo, R. L. Brost, C. Boone, T. R. Hughes, et al.
Molecular chaperone Hsp90 stabilizes Pih1/Nop17 to maintain R2TP complex activity that regulates snoRNA accumulation
J. Cell Biol.,
February 6, 2008;
180(3):
563 - 578.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|